Comparative Pharmacology
Head-to-head clinical analysis: ECONOPRED versus MAXITROL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ECONOPRED versus MAXITROL.
ECONOPRED vs MAXITROL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Prednisolone acetate is a corticosteroid that binds to glucocorticoid receptors, modulating gene expression to reduce inflammation, immune response, and vascular permeability.
Maxitrol is a combination of dexamethasone (corticosteroid), neomycin (aminoglycoside antibiotic), and polymyxin B (polymyxin antibiotic). Dexamethasone suppresses inflammation by inhibiting phospholipase A2, reducing prostaglandin and leukotriene synthesis. Neomycin binds to bacterial 30S ribosomal subunit, causing misreading of mRNA and inhibiting protein synthesis. Polymyxin B disrupts bacterial cell membrane integrity by binding to lipopolysaccharides.
1 drop in the affected eye(s) every 1-2 hours during the day and every 2 hours at night until clinical response, then reduce frequency to 1 drop every 4 hours, then 1 drop 3-4 times daily. Ophthalmic suspension, 1% prednisolone acetate equivalent.
1-2 drops or 0.5-1 inch strip of ointment into the conjunctival sac every 4-6 hours; in severe cases, every 2-4 hours. Frequency may be reduced after improvement.
None Documented
None Documented
Terminal elimination half-life is approximately 2-4 hours for prednisolone. However, the biological half-life (duration of adrenal suppression) is 24-36 hours due to intracellular receptor binding and slow dissociation.
Neomycin: 2–3 h (topical) but prolonged in renal impairment. Polymyxin B: 6–7 h (topical). Dexamethasone: 3–4 h (topical). Clinical: systemic absorption minimal with intact epithelium; half-life may be prolonged with corneal abrasion or inflammation.
Prednisolone is primarily metabolized in the liver; metabolites are excreted renally. Approximately 60-70% of a dose is excreted in urine as metabolites, with less than 10% as unchanged drug. Fecal excretion accounts for 10-15%.
Renal: neomycin 30–50%; polymyxin B <1%; dexamethasone <1%. Fecal: neomycin >50% (unabsorbed); polymyxin B >99% (unabsorbed); dexamethasone <5%. Biliary: negligible for all components.
Category C
Category C
Ophthalmic Corticosteroid
Ophthalmic Corticosteroid/Antibiotic Combination